The Significance of Autoantibodies in Juvenile Dermatomyositis
Juvenile dermatomyositis is a chronic and rare autoimmune disorder classified into the spectrum of idiopathic inflammatory myopathies. Although this entity is mainly characterized by the presence of pathognomonic cutaneous lesions and proximal muscle weakness, the clinical manifestation can be highl...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c6ee315e713b4053b714a291d2b824f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c6ee315e713b4053b714a291d2b824f1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c6ee315e713b4053b714a291d2b824f12021-11-29T00:56:37ZThe Significance of Autoantibodies in Juvenile Dermatomyositis2314-614110.1155/2021/5513544https://doaj.org/article/c6ee315e713b4053b714a291d2b824f12021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/5513544https://doaj.org/toc/2314-6141Juvenile dermatomyositis is a chronic and rare autoimmune disorder classified into the spectrum of idiopathic inflammatory myopathies. Although this entity is mainly characterized by the presence of pathognomonic cutaneous lesions and proximal muscle weakness, the clinical manifestation can be highly heterogeneous; thus, diagnosis might be challenging. Current treatment recommendations for juvenile dermatomyositis, based mainly upon case series, include the use of corticosteroids, immunomodulatory, and immunosuppressive agents. Recently, several specific autoantibodies have been shown to be associated with distinct clinical phenotypes of classic dermatomyositis. There is a need to further evaluate their relevance in the formation of various clinical features. Furthermore, while providing more personalized treatment strategies, one should consider diversity of autoantibody-related subgroups of juvenile dermatomyositis.Dominika KwiatkowskaAdam ReichHindawi LimitedarticleMedicineRENBioMed Research International, Vol 2021 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R |
spellingShingle |
Medicine R Dominika Kwiatkowska Adam Reich The Significance of Autoantibodies in Juvenile Dermatomyositis |
description |
Juvenile dermatomyositis is a chronic and rare autoimmune disorder classified into the spectrum of idiopathic inflammatory myopathies. Although this entity is mainly characterized by the presence of pathognomonic cutaneous lesions and proximal muscle weakness, the clinical manifestation can be highly heterogeneous; thus, diagnosis might be challenging. Current treatment recommendations for juvenile dermatomyositis, based mainly upon case series, include the use of corticosteroids, immunomodulatory, and immunosuppressive agents. Recently, several specific autoantibodies have been shown to be associated with distinct clinical phenotypes of classic dermatomyositis. There is a need to further evaluate their relevance in the formation of various clinical features. Furthermore, while providing more personalized treatment strategies, one should consider diversity of autoantibody-related subgroups of juvenile dermatomyositis. |
format |
article |
author |
Dominika Kwiatkowska Adam Reich |
author_facet |
Dominika Kwiatkowska Adam Reich |
author_sort |
Dominika Kwiatkowska |
title |
The Significance of Autoantibodies in Juvenile Dermatomyositis |
title_short |
The Significance of Autoantibodies in Juvenile Dermatomyositis |
title_full |
The Significance of Autoantibodies in Juvenile Dermatomyositis |
title_fullStr |
The Significance of Autoantibodies in Juvenile Dermatomyositis |
title_full_unstemmed |
The Significance of Autoantibodies in Juvenile Dermatomyositis |
title_sort |
significance of autoantibodies in juvenile dermatomyositis |
publisher |
Hindawi Limited |
publishDate |
2021 |
url |
https://doaj.org/article/c6ee315e713b4053b714a291d2b824f1 |
work_keys_str_mv |
AT dominikakwiatkowska thesignificanceofautoantibodiesinjuveniledermatomyositis AT adamreich thesignificanceofautoantibodiesinjuveniledermatomyositis AT dominikakwiatkowska significanceofautoantibodiesinjuveniledermatomyositis AT adamreich significanceofautoantibodiesinjuveniledermatomyositis |
_version_ |
1718407734027616256 |